The International Registry for Alzheimer's Disease and Other Dementias (InRAD): An International Registry Observational Study Dedicated to Evaluating Outcomes Data in Alzheimer's Disease

What this Trial Is About

Researchers are conducting an international observational study to collect and analyze long-term data on people with Alzheimer's disease (PwAD). The study aims to improve understanding of the disease by tracking disease progression, treatment safety, and outcomes using real-world data from many global clinical centers. It includes adults who are either undergoing diagnostic work-up or already diagnosed with Alzheimer's disease. Participants in this study are followed during their routine clinical visits, which occur at least once a year or more often as needed for their care. The study involves collecting medical information through a web-based platform, including patient demographics, disease status, clinical outcomes, safety data, and treatment details. Additional information such as lifestyle, biomarkers, imaging, and quality of life may also be collected. This is a non-interventional study, meaning no treatments are assigned by the study; instead, data on usual care and treatments are recorded. During participation, individuals will visit their doctors as part of their normal care, and data will be gathered during or after these visits. Researchers will monitor changes in Alzheimer's disease clinical stages over a period of up to 10 years, along with safety information related to treatments. Serious adverse events and other medical events are recorded to support long-term safety analyses. Participation does not involve any study-specific treatments or procedures beyond routine care, and there is no financial reimbursement for participants. Data privacy is maintained through pseudonymization and ethical oversight by participating centers.

InRAD Observational Study